Perennial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Perennial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	178
2021 Q2	$0	Buy	+1	New	+$173	﹤0.01%	303

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Perennial Advisors's JAZZ Position: Q3 2021 in Review

Perennial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 1 share.

Perennial Advisors first reported a position in JAZZ in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Perennial Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Perennial Advisors sold 1 Jazz Pharmaceuticals share in Q3 2021.
Perennial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 1 quarter.
Perennial Advisors's Jazz Pharmaceuticals position peaked at $0 in Q2 2021.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Perennial Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.